Primary Care Management of Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections

Methicillin-Resistant Staphylococcus Aureus Clinical Trial

Official title:

Management by Primary Care Clinicians of Patients Suspected of Having Community-Acquired, Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Infections

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00996112
• Other study ID #: 09-0265
• Secondary ID: AHRQ 04-109-6314
• Status: Completed
• Phase: N/A
• First received: October 15, 2009
• Last updated: January 23, 2013
• Start date: October 2009
• Est. completion date: August 2010

Study information

• Verified date: November 2010
• Source: University of Colorado, Denver
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

The goal of this study is to further the investigators' understanding of community acquired methicillin-resistant Staph Aureus (CA-MRSA) and treatment of it by developing real-world sustainable strategies consistent with existing guidelines on treatment of CA-MRSA from the Centers for Disease Control and Prevention (CDC) and test these strategies in busy primary care settings.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4518
• Est. completion date: August 2010
• Est. primary completion date: May 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A to 89 Years

Eligibility

Inclusion Criteria:

• All patients presenting at a primary care clinic who have a skin or soft tissue infection.

Exclusion Criteria:

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Methicillin-Resistant Staphylococcus Aureus
• Staphylococcal Infections

Locations

Country	Name	City	State
United States	University of Colorado Denver	Aurora	Colorado

Sponsors (2)

Lead Sponsor	Collaborator
University of Colorado, Denver	American Academy of Family Physicians National Research Network

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Physician Behavior Change	Intervention in practice for guideline-concordant care of CA MRSA	Throughout study participation	Yes